Atherosclerotic Risk Factors in Children with Celiac Disease

Table 5

Analysis of the biochemical parameters in the prospective group: test I was obtained on the day of diagnosis, and test II was obtained 12 months after introducing the gluten-free diet. Significant results are shown with bold font.

Parameter	Test I		Test II		value
	Mean	SD	Mean	SD
TCH	156.78	32.86	161.94	28.76	1.000
TG	69.86	31.45	58.90	28.40	0.839
LDL-C	94.98	29.32	100.37	26.57	1.000
VLDL-C	13.00	4.90	11.61	5.27	1.000
HDL-C	48.73	16.28	49.90	13.51	1.000
TCH-HDL-C	3.60	1.55	3.53	1.41	1.000
LDL-C-HDL-C	2.28	1.39	2.26	1.22	1.000
ApoA1	1.32	0.44	1.35	0.38	1.000
ApoB	0.71	0.22	0.78	0.23	1.000
AI-B	2.05	1.01	1.91	0.84	1.000
B-A1	0.69	0.55	0.70	0.55	1.000
ApoE	14.88	4.08	14.08	3.26	1.000
Lp(a)	16.94	11.78	16.49	11.39	1.000
TAS	1.30	0.34	1.44	0.29	0.039
Homocysteine	9.89	8.26	8.38	2.12	1.000
Folic acid	12.07	9.34	5.61	2.09	0.001
Uric acid	4.97	1.47	4.72	0.99	1.000
hsCRP	0.57	0.37	0.39	0.19	0.029

SD: standard deviation; TCH: total cholesterol; TG: triglycerides; apoA1: apolipoprotein A1; APOB: apolipoprotein B; APOE: apolipoprotein E; Lp(a): lipoprotein (a); LDL-C: low-density cholesterol; VLDL-C: very low-density cholesterol; HDL-C: high-density cholesterol; TAS: total antioxidant status; TC/HDL-C, LDL-C/HDL-C, and A1/B: indicators of atherosclerosis; hsCRP: high-sensitivity CRP.